文献速递瓣膜病与结构性心脏病

TAVI患者中VARC高出血风险标准的患病率与预后意义

Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation.
PubMed 文献 · Heart · 2026-06-11

基于2007–2022年18个欧洲中心8464例TAVI患者,按VARC-HBR标准分层,23.2%为极高危、39.1%高危、24.5%中危、13.1%低危。院内出血率随风险等级递增(低危11.0%,中危17.2%,高危20.0%,极高危22.2%,p<0.001),2年MACE亦递增,出血后死亡风险升高(HR 1.71,95%CI 1.50–1.95)。

要点

  • 近60%TAVI患者为高或极高出血风险。
  • VARC-HBR分层可预测院内出血和2年MACE。
  • 出血事件后死亡风险升高,尤其前3个月。

核心结论

  • VARC-HBR标准可识别TAVI后不良事件风险更高的患者。
  • 院内出血并发症和长期心血管事件随VARC-HBR等级递增。

研究设计与样本

  • 多中心注册研究,纳入2007–2022年18个欧洲中心8464例TAVI患者。
  • 使用VARC-HBR标准将患者分为低、中、高或极高出血风险。
  • 主要结局为院内主要或危及生命的出血(VARC-2定义)。

主要发现

  • 极高危1966例(23.2%),高危3311例(39.1%),中危2075例(24.5%),低危1112例(13.1%)。
  • 院内出血率:低危11.0%,中危17.2%,高危20.0%,极高危22.2%(p<0.001)。
  • 2年MACE发生率:低危13.8%,中危13.1%,高危18.6%,极高危25.4%(p<0.001)。
  • 出血事件后死亡风险升高(HR 1.71,95%CI 1.50–1.95),前3个月尤其显著(HR 2.88,95%CI 2.33–3.56)。

关键数值与推荐

  • VARC-HBR标准用于TAVI患者出血风险分层。
  • 主要出血结局采用VARC-2定义。
  • 出血风险与出血关联在校正日历时间后仍显著。

临床怎么用

  • 可采用VARC-HBR标准对TAVI患者进行出血风险分层。
  • 高或极高出血风险患者需加强围术期出血预防与监测。
  • 出血事件后应警惕短期死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Valve Academic Research Consortium (VARC) recently proposed a definition of high bleeding risk (HBR) for patients undergoing transcatheter aortic valve implantation (TAVI). This study aims to evaluate the prevalence and distribution of the VARC-HBR criteria and their ability to predict in-hospital bleeding. METHODS: Patients undergoing TAVI at 18 European sites between 2007 and 2022 and included in the Transfusion Requirements in Transcatheter Aortic Valve Implantation (NCT03740425) registry were stratified into low, moderate, high or very high bleeding risk using the VARC-HBR criteria. The primary outcome was in-hospital major or life-threatening bleeding (VARC-2 definition). RESULTS: Among 8464 patients, bleeding risk was very high in 1966 (23.2%), high in 3311 (39.1%), moderate in 2075 (24.5%) and low in 1112 (13.1%). In-hospital bleeding occurred in 11.0% of those at low risk, compared with 17.2%, 20.0% and 22.2% of patients at moderate, high and very high risk (p<0.001). The association between VARC-HBR criteria and bleeding remained significant after adjustment for calendar time. At 2 years, the incidence of major adverse cardiovascular events ranged from 13.8% in low-risk patients to 13.1%, 18.6% and 25.4% among those at moderate, high and very high risk (p<0.001). Mortality was higher after a bleeding event (HR 1.71, 95% CI 1.50 to 1.95), especially within the first 3 months (HR 2.88, 95% CI 2.33 to 3.56). CONCLUSIONS: Up to 60% of patients undergoing TAVI are at high or very high bleeding risk. The VARC-HBR criteria identified those at greater risk of adverse events. In-hospital bleeding complications and long-term cardiovascular events increased progressively across VARC-HBR categories.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Cao D, Sandri M, Garot P, et al. Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation. Heart. 2026. PMID: 40803818. doi:10.1136/heartjnl-2025-326043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。